Filter:

Bayer to Present Pulmonary Hypertension Data at the American Thoracic Society 2017 International Conference
» more
Bayer U.S. Leaders Honored by Healthcare Businesswomen's Association for Outstanding Achievement
» more
Bayer to Highlight Oncology Franchise Research at ASCO 2017
Abstracts: 5042, 3567, 3551, 4078, 6084, TPS5092, 7535, 7536, 7563
» more
FDA Grants Bayer Priority Review for Investigational Compound Copanlisib in Follicular Lymphoma
- Regulatory submission based on data from the Phase II CHRONOS-1 study, in which copanlisib met its primary endpoint of objective response rate
» more
Bayer, the maker of Bayer® Aspirin, Supports American Stroke Association's Together to End Stroke™ Initiative to Raise Awareness of Secondary Prevention of Stroke
Women have a higher lifetime risk of stroke than men
» more
Five U.S. Delegates Among 100 Young Leaders Appointed to Help Tackle Global Food Security Challenge at International Agriculture Summit
More than 1,000 applied as delegates for the 2017 Youth Ag-Summit to be held October 9-13 in Brussels, Belgium
» more
Bayer Appoints Bhavesh Ashar to Lead U.S. Oncology Business
» more
Three New Research Proposals Funded By Healthy Hives 2020 Initiative
Latest awards part of multi-year effort to improve honey bee colony health by 2020
» more
Bayer Receives FDA Approval for Stivarga® (regorafenib) for the Second-Line Systemic Treatment of Liver Cancer
- Stivarga is the first and only systemic treatment to demonstrate significant improvement in overall survival in second-line hepatocellular carcinoma (HCC) patients previously treated with Nexavar® (sorafenib)
» more
Bayer on Target to Shatter Goal of Providing 1 Million Hands-On Science Experiences for Students in the United States by 2020
Company Surpasses Halfway Mark of Five-Year Commitment Aimed at Inspiring Next Generation of Innovators
» more